You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. High Performance Electric-Field Sensor Based on Enhanced Electro-Optic Polymer Refilled Slot Photonic Crystal Waveguides

    SBC: OMEGA OPTICS, INC.            Topic: AF11BT01

    ABSTRACT: This Phase II STTR research proposal aims to demonstrate an antenna coupled phase modulator based on an Electro-optic (EO) polymer refilled slot photonic crystal waveguide (PCW) for operation in the Q band. The goal is to detect field strengths of 100uW/m^2 in an Intensity Modulation Direct Detection (IMDD) scheme using subwavelength antennas. The EO polymer is the SEO125 provided by Dr ...

    STTR Phase II 2014 Department of DefenseAir Force
  2. Use of Micro Plasma Based Transistors for the Development of Compact High Frequency Power Supplies

    SBC: LYNNTECH INC.            Topic: AF13AT07

    ABSTRACT: Pulsed power systems are utilized in several application platforms ranging from fuel reforming to biomedical applications. While significant advances have been made in development of solid state technology based power systems, the need for faster pulse rates as well as higher voltage requirements have resulted in a need for developing novel pulse power sources capable of pulsing at freq ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. Voxel-based Fusion (VOXION)

    SBC: 21ST CENTURY SYSTEMS, INC.            Topic: AF13AT01

    ABSTRACT: In ISR applications, multiple sensors can be employed to achieve more accurate parameters of interest on targets, improving discrimination and detection. But, the proliferation of sensor systems has created a large volume of multi-sensor data across a number of physical spectra. These resulting measurements can be so disparate that traditional aggregation methods perform poorly given h ...

    STTR Phase I 2014 Department of DefenseAir Force
  4. Electronic Warfare: EMS Monitor&Broadcast Training Capacity Enhancement

    SBC: KERBEROS INTERNATIONAL, INC.            Topic: AF14AT28

    ABSTRACT: Kerberos and SwRI plan to develop and evaluate new monitoring and broadcasting methods in a laboratory environment in the context of expected current and future military RF operating environments. Our proposed solution, called Electromagnetic Spectrum Monitor & Broadcast System (EMBS), will create a low-cost, small packaged device that can emulate anticipated opposing force broadcastin ...

    STTR Phase I 2014 Department of DefenseAir Force
  5. Low-Cost, High-Throughput Roll-to-Roll Printing of Integrated Photonic Devices on Flexible Substrates via a Combination of Nanoimprinting and Ink-Jet

    SBC: OMEGA OPTICS, INC.            Topic: AF11BT05

    ABSTRACT: In this program, Omega Optics, Inc., in collaboration with the University of Michigan Ann Arbor and the University of Texas at Austin, proposes to develop integrated photonic devices by using a combination of high-rate R2R nanoimprint lithography (R2RNIL) and R2R ink-jet printing. Patterning of photonic devices with sub-wavelength (

    STTR Phase II 2014 Department of DefenseAir Force
  6. Ex vivo purging strategy for treatment of multiple myeloma

    SBC: DNATRIX INC            Topic: NCI

    DESCRIPTION (provided by applicant): The ultimate goal of this application is to develop a novel ex vivo purging method using myxoma virus (MYXV), a rabbit-specific poxvirus, to improve the clinical outcomes in treatment of multiple myeloma (MM). MM is aclonal plasma cell malignancy that has to date resisted essentially all therapeutic strategies. Currently, the standard of care for patients wit ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. CMV Vectored Herpes Simplex Vaccine

    SBC: TOMEGAVAX, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The longterm goal of this project is to utilize cytomegalovirus (CMV) vectors in the development of a therapeutic vaccine against herpes simplex virus 2 (HSV-2), the causative agent of genital herpes. HSV-2 is widely prevalent in the population causing recurrent genital lesions and significantly increasing the risk for other sexually transmitted diseases such a ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Mucins in the Diagnosis and Prognosis of Pancreatic Diseases

    SBC: Sanguine Diagnostics And Therapeutics, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Due to its asymptomatic nature and lack of methods for early detection, gt 80% of pancreatic cancer (PC) patients present with an unresectable primary tumor with distant metastasis at the time of diagnosis. While the overall 5 year survival rate of pancreatic cancer is dismal, significantly better outcomes have been reported for smaller tumors detected at an e ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Screening for Novel CBS Inhibitors for Cancer Therapy

    SBC: CBS THERAPEUTICS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Recent studies of the applicants support the role of the endogenous gaseous biological mediator hydrogen sulfide (H2S) in colorectal cancer: selective upregulation of cystathionine-b-synthase (CBS) and the subsequent production of H2S in colonic cancer cells serves as a pro-survival factor by stimulating tumor cell bioenergetics, growth, proliferation, migratio ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government